Aquestive Therapeutics Inc (NAS:AQST)
$ 3.27 0.18 (5.83%) Market Cap: 297.69 Mil Enterprise Value: 220.59 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

Aquestive Therapeutics Inc at JMP Securities Life Sciences Conference Transcript

Jun 16, 2022 / 01:00PM GMT
Release Date Price: $0.7268 (-17.80%)
Jason Butler
JMP Securities - Analyst

Good morning. Thanks, everybody, for joining us again at the JMP Securities Life Science Conference. Really appreciate everybody being here in-person with us today. Starting off the morning with Aquestive Therapeutics. Excited to have Dan Barber, the company's CEO; and Ernie Toth, CFO. So welcome, Dan and Ernie.

Maybe just -- obviously, you put out some exciting data for your epinephrine program yesterday. You have the epilepsy program still working through FDA, so lots to talk about. Maybe I'll just hand it over to you, Dan, to give a quick intro.

And I think, maybe, just one important point to hit on is you took over as CEO a few weeks ago now, and I'm sure it's been a fast pace, an exciting experience. But you've been at the company a long time, so just hearing your vision would be a great place to start.

Dan Barber
Aquestive Therapeutics, Inc. - CEO, President & Director

Sure, and thank you, Jason. And thank you to JMP for having us here. My vision is quite simple. AQST-109 is, by far, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot